BioMedNewsBreaks Archive - Page 95 of 253

WednesdayDec 06, 2023 1:28 pm

BioMedNewsBreaks — Astiva Health Partners with IBN to Deliver Corporate Communications, Increase Awareness

Astiva Health, a leading healthcare provider that specializes in delivering personalized and comprehensive healthcare solutions to diverse communities, has selected IBN, a versatile financial news and publishing company specializing in private and public entities, as a corporate communications partner. According to the announcement, the partnership is designed to enhance Astiva Health's corporate communications initiatives as the company focuses on its mission to deliver unparalleled quality care and establish enduring relationships within the community. Astiva Health is building a reputation for offering comprehensive healthcare solutions to diverse communities, with services rooted in a commitment to community-based healthcare and customized benefit packages aimed at…

WednesdayDec 06, 2023 12:36 pm

BioMedNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Interim Analysis on Global Berubicin Trial Showing Promising Results

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company focused on developing innovative therapies for central nervous system disorders, specifically aggressive brain cancers. In September, the company announced that 200 out of 243 expected patients had been enrolled in its ongoing study evaluating the effectiveness of Berubicin for recurrent glioblastoma (“GBM”), a highly aggressive and incurable form of brain cancer. The critical and adaptive global trial involves multiple centers and is open-label, randomized and controlled, comparing Berubicin to Lomustine - the standard of care - in adult patients with recurrent GBM (“WHO Grade IV”) after standard first-line therapy has failed. The…

TuesdayDec 05, 2023 4:36 pm

BioMedNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Closes Non-Brokered Private Placement

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) today announced that it has closed a non-brokered private placement and issued 24 class A multiple voting shares of the company, each at a price of $1.90, for gross proceeds of $45.60 (the “offering”). All securities issued pursuant to the offering are subject to a statutory hold period of four months plus a day from issuance in accordance with applicable securities laws of Canada. FSD Pharma intends to use the proceeds of the offering for general working capital purposes. To view the full press release, visit https://ibn.fm/NQ4uk About FSD Pharma Inc. FSD…

TuesdayDec 05, 2023 3:25 pm

BioMedNewsBreaks – SOHM, Inc. (SHMN) Announces 2024 Outlook for Business Units

SOHM (OTC: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, today announced its outlook for 2024 for each of its business units. SOHM is organized into the following business units: OTC Self-care (over-the-counter nutraceuticals and cosmeceuticals), Branded Generics (off-patent prescription pharmaceuticals), CDMO, Contract Development Manufacturing (contract manufacturing services), and ABBIE, Gene-editing Bio-kits. As detailed in the announcement, for each of these units, the company provided its outlook for the upcoming year along with relevant unit-specific status on: market backgrounds, business strategy and model, branding strategy, sales channels, and commercial status. To…

TuesdayDec 05, 2023 2:45 pm

BioMedNewsBreaks – Safety Shot (NASDAQ: SHOT) Releases Updated Report on Litigation

Safety Shot (NASDAQ: SHOT), makers of the first patented beverage on Earth that helps people feel better faster by reducing blood alcohol content and boosting clarity, is reporting on its newly filed lawsuit against Capybara Research. According to the update, the company filed a federal lawsuit in the U.S. District Court for the Southern District of New York against Capybara Research on Dec. 4, 2023. In addition, the company is reporting that after weeks of investigatory work by counsel along with third-party assistance and cooperation, the person responsible for the malicious article has been identified. The company is now taking steps…

MondayDec 04, 2023 3:01 pm

BioMedNewsBreaks – ROTH MKM and Sustain SoCal to Co-Host Upcoming PCE6 Event

ROTH MKM and Sustain Southern California (“Sustain SoCal”) today announced plans to jointly host the 6th Annual Sustainability Private Capital Event (“PCE6”), which will take place in a virtual format on Wednesday, Dec. 6, 2023, and Thursday, Dec. 7, 2023. This year’s conference will feature Company Quick Pitches and 1-on-1 / small group ZOOM meetings, providing investors the opportunity to meet with early-stage sustainability companies in cutting-edge domains, including solar/storage, hydrogen, e-mobility, smart city, circular economy, water and agtech. “The outlook within the sustainability sector remains mixed. The recent passing of the IRA, the IIJA, as well as a series…

MondayDec 04, 2023 2:53 pm

BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Featured in Recent H.C. Wainwright & Co. Research Report with ‘Buy’ Rating, $3 PT

PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, is spotlighted in a recent H.C. Wainwright & Co. research report. The report “is initiating coverage on PaxMedica, an emerging firm developing novel formulations of suramin for treatment of neurological disorders with intractable symptoms,” which is “attacking autism with a novel approach.” The report noted that PaxMedica was the first company to design and execute a controlled clinical study based on the agency’s inputs, with top-line data based on retrospective analysis of medical records being presented in November 2023 that “showed PAX-101 (intravenous suramin) clinical meaningfulness in…

MondayDec 04, 2023 1:59 pm

BioMedNewsBreaks – Safety Shot (NASDAQ: SHOT) Announces Sellout of Product ‘Almost Immediately’ After Being Released on Amazon.com

Safety Shot (NASDAQ: SHOT), a wellness and functional beverage company, announced that its flagship product, Safety Shot, sold out within hours after being released on Amazon.com. The scientifically formulated beverage is the first patented beverage that helps consumers feel better faster by reducing blood alcohol content and boosting clarity. The announcement noted that the product was released on Amazon on Nov. 30, 2023, and without any introduction or announcement, Safety Shot sold out almost immediately. Amazon is the first direct-to-consumer platform to carry Safety Shot, which can also be purchased from the company’s website; the company also anticipates the product…

FridayDec 01, 2023 2:59 pm

BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Targeting Confirmatory Support for Existing ALS Trial Data with NIH-Funded EAP Study

Clene’s (NASDAQ: CLNN) wholly owned subsidiary Clene Nanomedicine Inc. and its collaborators, Columbia University and Synapticure, recently received a four-year grant totaling $45.1 million. The grant will support an Expanded Access Protocol (“EAP”) study investigating the safety and efficacy of Clene’s investigational product (“IP”), CNM-Au8, as a treatment for people with amyotrophic lateral sclerosis (“ALS”). “CNM-Au8 is an orally administered gold nanocrystal suspension that is thought to improve mitochondrial health and protect neuronal function to treat neurodegenerative diseases. This IP, which clinical studies have shown is well tolerated, can penetrate the blood-brain barrier, stimulate energy production and utilization, and reduce…

FridayDec 01, 2023 2:10 pm

BioMedNewsBreaks – IBN and BioMedWire Extend Collaboration with Dynamic Global Events

IBN, a comprehensive communications organization with a diverse portfolio of 60+ brands, today announced its fourth consecutive year of collaboration with Dynamic Global Events (“DGE”), a leader in B2B conferences that serve the pharmaceutical and life sciences industries. IBN will serve as an official media partner for the upcoming DGE events in 2024. In addition, BioMedWire (“BMW”), a digital hub within IBN committed to highlighting emerging opportunities in the life sciences industry, will join as an official media partner to further enhance the media coverage of DGE’s events throughout the year. DGE events foster education, networking, business development and partnership…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

BioMedNewsBreaks

BioMedNewsBreaks — Astiva Health Partners with IBN to Deliver Corporate Communications, Increase Awareness

BioMedNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Interim Analysis on Global Berubicin Trial Showing Promising Results

BioMedNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Closes Non-Brokered Private Placement

BioMedNewsBreaks – SOHM, Inc. (SHMN) Announces 2024 Outlook for Business Units

BioMedNewsBreaks – Safety Shot (NASDAQ: SHOT) Releases Updated Report on Litigation

BioMedNewsBreaks – ROTH MKM and Sustain SoCal to Co-Host Upcoming PCE6 Event

BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Featured in Recent H.C. Wainwright & Co. Research Report with ‘Buy’ Rating, $3 PT

BioMedNewsBreaks – Safety Shot (NASDAQ: SHOT) Announces Sellout of Product ‘Almost Immediately’ After Being Released on Amazon.com

BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Targeting Confirmatory Support for Existing ALS Trial Data with NIH-Funded EAP Study

BioMedNewsBreaks – IBN and BioMedWire Extend Collaboration with Dynamic Global Events

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search